• 1. A green synthetic approach to synthesizing diverse 2-pyridones for their exceptional UV shielding functions
  Shizuka Mei Bautista Maezono,Tej Narayan Poudel,Likai Xia,Yong Rok Lee RSC Adv. 2016 6 82321
• 2. Analytical chemistry
  J. Chem. Soc. Abstr. 1910 98 ii66

Methyl 2-Hydroxypyridine-3-Carboxylate (CAS No. 10128-91-3): A Key Intermediate in Modern Pharmaceutical Synthesis

Methyl 2-hydroxypyridine-3-carboxylate (CAS No. 10128-91-3) is a versatile and highly valuable intermediate in the field of pharmaceutical synthesis. This compound, characterized by its unique structural properties, has garnered significant attention in recent years due to its applications in the development of novel therapeutic agents. The molecule's dual functionality, featuring both a hydroxyl group and a carboxylate ester, makes it an indispensable building block for synthetic chemists.

The chemical structure of methyl 2-hydroxypyridine-3-carboxylate consists of a pyridine ring substituted at the 2-position with a hydroxyl group and at the 3-position with a methyl ester of a carboxylic acid. This configuration imparts distinct reactivity patterns that are exploited in various synthetic pathways. The hydroxyl group at the 2-position allows for nucleophilic substitution reactions, while the ester moiety at the 3-position can be hydrolyzed to yield the corresponding carboxylic acid or undergo transesterification to introduce different alkyl groups.

In recent years, significant advancements have been made in the utilization of methyl 2-hydroxypyridine-3-carboxylate in the synthesis of bioactive molecules. One notable area of research involves its application in the development of kinase inhibitors, which are crucial for treating cancers and inflammatory diseases. The pyridine core is a common scaffold in many kinase inhibitors due to its ability to interact favorably with the ATP-binding site of these enzymes. The presence of both hydroxyl and ester functionalities provides multiple sites for derivatization, allowing chemists to fine-tune the pharmacokinetic properties of these inhibitors.

Moreover, methyl 2-hydroxypyridine-3-carboxylate has found utility in the synthesis of antiviral agents. The structural motif is present in several approved antiviral drugs, where it contributes to binding affinity and specificity against viral proteases and polymerases. Researchers have leveraged its reactivity to develop novel analogs with enhanced efficacy and reduced side effects. For instance, recent studies have demonstrated the use of this compound in generating protease inhibitors for HIV and hepatitis C viruses, showcasing its importance in combating infectious diseases.

The compound's role extends beyond small-molecule drug development. It serves as a precursor in the synthesis of heterocyclic compounds, which are widely used as ligands in catalysis and as intermediates in materials science. The pyridine ring's electron-deficient nature makes it an excellent ligand for transition metals, facilitating various catalytic transformations such as cross-coupling reactions and hydrogenation processes. These reactions are pivotal in industrial applications, including the production of fine chemicals and polymers.

Recent innovations in synthetic methodologies have further highlighted the significance of methyl 2-hydroxypyridine-3-carboxylate. For example, asymmetric synthesis techniques have been employed to produce enantiomerically pure derivatives of this compound, which are essential for drugs requiring high stereochemical control. Additionally, green chemistry approaches have been explored to develop more sustainable synthetic routes, minimizing waste and reducing environmental impact. These efforts align with global initiatives to promote sustainable pharmaceutical manufacturing.

The versatility of methyl 2-hydroxypyridine-3-carboxylate is also evident in its application as a chiral auxiliary in peptide mimetics. The hydroxyl group can be used to introduce stereocenters that mimic peptide bonds, enabling the design of peptidomimetics with improved bioavailability and metabolic stability. Such mimetics are valuable tools in drug discovery, offering alternatives to natural peptides with similar biological activity but enhanced pharmacological profiles.

In conclusion, methyl 2-hydroxypyridine-3-carboxylate (CAS No. 10128-91-3) is a cornerstone intermediate in modern pharmaceutical synthesis. Its unique structural features enable diverse applications across multiple therapeutic areas, including oncology, virology, and materials science. As research continues to uncover new synthetic possibilities and therapeutic applications, this compound will undoubtedly remain a critical component in the arsenal of medicinal chemists worldwide.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)